Pharmacokinetics of a new microemulsion formulation of cyclosporin A (Neoral) in young patients after renal transplantation

Transplant International

Volumn 9, Issue 5, 1996, Pages 476-480

  Krmar, Rafael T ^a   Wühl, Elke ^a   Ding, Reinhard ^a   Aulmann, Michael ^a   Schärer, Karl ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CyA, pediatric kidney transplantation; Neoral, pediatric kidney transplantation; Pediatric kidney transplantation, CyA

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INULIN;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG MONITORING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INULIN CLEARANCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029761251     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb00991.x     Document Type: Article

References (22)

1. Bokenkamp A, Offner G, Hoyer PF, Vester U, Wonigeit K, Brodehl J (1995) Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring. Pediatr Nephrol 9: 196-198
2. Curtis JJ, Bubovsky E, Welchel JD, Luke RG, Diethelm AG, Jones P (1986) Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet II: 477-479
3. Drewe J, Meier R, Vonderscher J, Kiss D, Posanski U, Kissel T, Gyr K (1992) Enhancement of the oral absorption of cyclosporin in man. Br J Clin Pharmacol 34: 60-64
4. Foradori AC, Martinez L, Vacarezza A, Elberg L, Loveluck A, Pinto C (1994) Pharmacokinetics of a new galenical formulation of oral cyclosporine A in stable transplanted patients. Transplant Proc 26: 2969-2972
5. Holford NHG (1988) MKMODEL. An extended least squares modelling program. Biosoft, Cambridge, UK
6. Holt DW, Mueller EA, Kovarik JM, Bree JB van, Kutz K (1994) The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine. Transplant Proc 26: 2935-2939
7. Hoppu H, Koskimies O, Holmberg C, Hirvisalo EL (1991) Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol 5: 1-4
8. Kovank JM, Mueller EA, Bree JB van, Flückiger S, Lange H, Schmidt B, Boeskin WH, Lison AE, Kutz K (1994) Cyclosporine pharmacokinetics and variability from a microemulsion formulation: a multicenter investigation in kidney transplant patients. Transplantation 58: 658-663
9. Kovarik JM, Kallay Z, Mueller EA, Bree JB van, Arns W, Renner E (1995) Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patients. Transpl Int 8: 335-339
10. Kuehnle HF, Dahl KV, Schmidt FH (1992) Fully enzymatic inulin determination in small volume samples without deproteinization. Nephron 62: 104-107
11. Lin CY, Lee SF (1994) Comparison of pharmacokinetics between CyA capsules and Sandimmun Neoral in pediatric patients. Transplant Proc 26: 2973-2974
12. Lindholm A, Dahlqvist R, Groth GG, Sjöqvist F (1990) A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation. Br J Clin Pharmacol 30: 443-452
13. Mueller EA, Kovarik JM, Bree JB van, Lison AE, Kutz K (1994) Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients - a concentration-controlled comparision with the commercial formulation. Transplantation 57: 1178-1182
14. Myers BD (1989) What is cyclosporine nephrotoxicity? Transplant Proc 21: 1430-1432
15. Neumayer HN, Färber L, Haller P, Kohnen R, Maibücher A, Schuster A, Vollmar J, Waiser J (1995) Clinical experience transfering kidney transplant patients from Sandimmun to Sandimmun Neoral - results after 3 months. Clin Nephrol 43: S27-S32
16. Opelz G (1994) Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 58: 443-446
17. Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G (1992) Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54: 56-60
18. Ptachcinski RJ, Burckart GJ, Rosenthal JT, Venkataramanan R, Howrie DL, Taylor RJ, Avner ED, Ellis D, Hakala TR (1986) Cyclosporine pharmacokinetics in children following cadaveric renal trasplantation. Transplant Proc 38: 766-767
19. Ruder H, Strehlau J, Schaefer F, Gretz N, Müller-Wiefel DE, Bonzel KE, Möhring K, Pomer S, Mehls O, Schärer K (1989) Low-dose cyclosporin A therapy in cadaver renal transplantation in children. Transpl Int 2: 203-208
20. Taesch S, Niese D (1994) Safety and tolerability of the new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients. Transpl Int 7: [Suppl 1]: 263-266
21. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Illinois, pp 102-107
22. Wandstrat TL, Schroeder TJ, Myre S (1989) Cyclosporine pharmacokinetics in pediatric transplant recipients. Ther Drug Monit 5: 493-496